Influx Healthtech Limited (NSE:INFLUX)
India flag India · Delayed Price · Currency is INR
246.20
-3.95 (-1.58%)
At close: Jun 1, 2026

Influx Healthtech Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,4681,049999.65760.57592.02
Revenue Growth (YoY)
40.04%4.89%31.44%28.47%-
Cost of Revenue
866.91639.48656.01528.63456.38
Gross Profit
601.43409.05343.65231.94135.64
Selling, General & Admin
117.55100.2982.2161.4539.8
Other Operating Expenses
171.95102.0691.6163.2534.15
Operating Expenses
327.28230.6192.36134.0875.16
Operating Income
274.15178.46151.2897.8660.48
Interest Expense
-1.84-0.01-1.71-0.1-0.05
Interest & Investment Income
-0.560.23--
Currency Exchange Gain (Loss)
--0.220.01--
Other Non Operating Income (Expenses)
-0-0.48-0.4-0.37
Pretax Income
272.31178.79149.3397.3660.06
Income Tax Expense
66.9245.1338.0525.415.69
Net Income
205.39133.66111.2871.9644.37
Net Income to Common
205.39133.66111.2871.9644.37
Net Income Growth
53.66%20.11%54.63%62.20%-
Shares Outstanding (Basic)
2218181818
Shares Outstanding (Diluted)
2218181818
Shares Change (YoY)
21.03%---0.00%0.00%
EPS (Basic)
9.357.366.133.962.44
EPS (Diluted)
9.357.366.133.962.44
EPS Growth
27.04%20.06%54.80%62.00%-
Free Cash Flow
-206.75-11.555.8319.430.49
Free Cash Flow Per Share
-9.41-0.640.321.070.03
Gross Margin
40.96%39.01%34.38%30.50%22.91%
Operating Margin
18.67%17.02%15.13%12.87%10.22%
Profit Margin
13.99%12.75%11.13%9.46%7.49%
Free Cash Flow Margin
-14.08%-1.10%0.58%2.55%0.08%
EBITDA
311.93206.63169.74107.1961.7
EBITDA Margin
21.24%19.71%16.98%14.09%10.42%
D&A For EBITDA
37.7828.1718.469.331.22
EBIT
274.15178.46151.2897.8660.48
EBIT Margin
18.67%17.02%15.13%12.87%10.22%
Effective Tax Rate
24.57%25.24%25.48%26.09%26.13%
Revenue as Reported
1,4821,0501,000760.57592.02
Advertising Expenses
-0.190.21.250.14